Small molecule therapeutics for brain disorders

脑部疾病的小分子疗法

• 批准号: nhmrc : GNT1154692
• 负责人: Prof Michael Kassiou
• 金额: $ 78.54万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/small-molecule-therapeutics-brain-disorders/1349153
• 关键词: Small; molecule; therapeutics; brain; disorders

I will establish and advance the field of CNS drug discovery in Australia. I will train the next generation of researchers and research leaders with the breadth of skills to enable efficient and cost-effective drug discovery. I will deliver new drug candidates for CNS diseases by coordinating a greater part of the drug development pathway. I will lead research translation through multidisciplinary collaboration and to focus on interrelated features that are central to CNS diseases.

我将在澳大利亚建立并推进CNS药物发现领域。我将培训下一代研究人员和研究领导者的技能广度，以实现有效且具有成本效益的药物发现。我将通过协调大部分药物开发途径来为中枢神经系统疾病提供新的候选药物。我将通过多学科的合作来领导研究翻译，并专注于中枢神经系统疾病核心的相互关联特征。